Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Assessment of lymphatic flow based on the sentinel node concept in early gastric adenocarcinoma that satisfies expanded endoscopic resection criteria.

Takeuchi M, Kawakubo H, Shimada A, Matsuda S, Nakahara T, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y.

Gastric Cancer. 2019 Nov 14. doi: 10.1007/s10120-019-01026-7. [Epub ahead of print]

PMID:
31728803
2.

Utility of the one-step nucleic acid amplification assay in sentinel node mapping for early gastric cancer patients.

Shimada A, Takeuchi H, Nishi T, Mayanagi S, Fukuda K, Suda K, Nakamura R, Wada N, Kawakubo H, Nakahara T, Kameyama K, Kitagawa Y.

Gastric Cancer. 2019 Oct 30. doi: 10.1007/s10120-019-01016-9. [Epub ahead of print]

PMID:
31667687
3.

THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5 fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis.

Hayashi M, Kawakubo H, Fukuda K, Mayanagi S, Nakamura R, Suda K, Hayashida T, Wada N, Kitagawa Y.

J Gene Med. 2019 Oct 26:e3135. doi: 10.1002/jgm.3135. [Epub ahead of print]

PMID:
31656051
4.

Reply to comment on "Ambiguity about the volume of colloids administration in a clinical study of thoracic esophagectomy precludes conclusion on renal safety of hydroxyethyl starch".

Fujita T, Okada N, Horikiri Y, Sato T, Fujiwara H, Mayanagi S, Kanamori J, Yamamoto H, Daiko H.

Surg Today. 2019 Oct;49(10):886. doi: 10.1007/s00595-019-01844-3. Epub 2019 Jul 15. No abstract available.

PMID:
31309330
5.

Clinical outcomes of non-exposed endoscopic wall-inversion surgery for gastric submucosal tumors: long-term follow-up and functional results.

Aoyama J, Goto O, Kawakubo H, Mayanagi S, Fukuda K, Irino T, Nakamura R, Wada N, Takeuchi H, Yahagi N, Kitagawa Y.

Gastric Cancer. 2019 Jul 3. doi: 10.1007/s10120-019-00985-1. [Epub ahead of print]

PMID:
31270624
6.

Discrepancy Between the Clinical and Final Pathological Findings of Lymph Node Metastasis in Superficial Esophageal Cancer.

Aoyama J, Kawakubo H, Mayanagi S, Fukuda K, Irino T, Nakamura R, Wada N, Suzuki T, Kameyama K, Kitagawa Y.

Ann Surg Oncol. 2019 Sep;26(9):2874-2881. doi: 10.1245/s10434-019-07498-2. Epub 2019 Jun 17.

PMID:
31209674
7.

Thyroid and Parathyroid Functions After Pharyngo-Laryngo-Esophagectomy for Cervical Esophageal Cancer.

Saito Y, Kawakubo H, Takami H, Aoyama J, Mayanagi S, Irino T, Fukuda K, Suda K, Nakamura R, Wada N, Kitagawa Y.

Ann Surg Oncol. 2019 Oct;26(11):3711-3717. doi: 10.1245/s10434-019-07476-8. Epub 2019 Jun 11.

PMID:
31187362
8.

A low surgical Apgar score is a predictor of anastomotic leakage after transthoracic esophagectomy, but not a prognostic factor.

Hayashi M, Kawakubo H, Mayanagi S, Nakamura R, Suda K, Wada N, Kitagawa Y.

Esophagus. 2019 Oct;16(4):386-394. doi: 10.1007/s10388-019-00678-9. Epub 2019 Jun 5.

PMID:
31165934
9.

Comparison of olanexidine versus povidone-iodine for preventing surgical site infection in gastrointestinal surgery: study protocol for a multicentre, single-blind, randomised controlled clinical trial.

Takeuchi M, Obara H, Kawakubo H, Shinoda M, Okabayashi K, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitago M, Yagi H, Abe Y, Oshima G, Hori S, Tsuruta M, Ishida T, Yokose T, Hirukawa K, Isobe Y, Sekimoto Y, Harada H, Maeda Y, Shito M, Kondo T, Sato Y, Kitagawa Y.

BMJ Open. 2019 May 28;9(5):e028269. doi: 10.1136/bmjopen-2018-028269.

10.

Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer.

Mayanagi S, Irino T, Kawakubo H, Kitagawa Y.

Ann Gastroenterol Surg. 2019 Mar 1;3(3):269-275. doi: 10.1002/ags3.12243. eCollection 2019 May. Review.

11.

The Benefits of Docetaxel Plus Cisplatin and 5-Fluorouracil Induction Therapy in Conversion to Curative Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma.

Takeuchi M, Kawakubo H, Mayanagi S, Yoshida K, Irino T, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y.

World J Surg. 2019 Aug;43(8):2006-2015. doi: 10.1007/s00268-019-05000-3.

PMID:
30972432
12.

Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.

Takeuchi M, Kawakubo H, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y.

Ann Surg Oncol. 2019 Jul;26(7):2081-2089. doi: 10.1245/s10434-019-07312-z. Epub 2019 Apr 1.

PMID:
30937664
13.

Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma.

Nakamura R, Omori T, Mayanagi S, Irino T, Wada N, Kawakubo H, Kameyama K, Kitagawa Y.

World J Surg Oncol. 2019 Feb 13;17(1):32. doi: 10.1186/s12957-019-1571-2.

14.

[Future perspectives -multimodal treatment strategy for esophageal cancer].

Mayanagi S, Kawakubo H, Kitagawa Y.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(2):109-114. doi: 10.11405/nisshoshi.116.109. Japanese. No abstract available.

PMID:
30745547
15.

Safety and efficacy of hydroxyethyl starch 6% 130/0.4/9 solution versus 5% human serum albumin in thoracic esophagectomy with 3-field lymph nodes dissection.

Fujita T, Okada N, Horikiri Y, Sato T, Fujiwara H, Mayanagi S, Kanamori J, Yamamoto H, Daiko H.

Surg Today. 2019 May;49(5):427-434. doi: 10.1007/s00595-018-1752-6. Epub 2019 Jan 2.

PMID:
30604215
16.

Perioperative risk calculator for distal gastrectomy predicts overall survival in patients with gastric cancer.

Takeuchi M, Kawakubo H, Mayanagi S, Suzuki Y, Okabayashi K, Yamashita T, Kamiya S, Irino T, Fukuda K, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y.

Gastric Cancer. 2019 May;22(3):624-631. doi: 10.1007/s10120-018-0896-9. Epub 2018 Nov 26.

PMID:
30478691
17.

Analysis of the Effect of Early Versus Conventional Nasogastric Tube Removal on Postoperative Complications After Transthoracic Esophagectomy: A Single-Center, Randomized Controlled Trial.

Hayashi M, Kawakubo H, Shoji Y, Mayanagi S, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y.

World J Surg. 2019 Feb;43(2):580-589. doi: 10.1007/s00268-018-4825-1.

PMID:
30353406
18.

Potential for local resection with sentinel node basin dissection for early gastric cancer based on the distribution of primary sites.

Aoyama J, Kawakubo H, Goto O, Nakahara T, Mayanagi S, Fukuda K, Suda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y.

Gastric Cancer. 2019 Mar;22(2):386-391. doi: 10.1007/s10120-018-0865-3. Epub 2018 Aug 11.

PMID:
30099636
19.

Gastric inflammatory myofibroblastic tumor treated with combined laparoscopic and endoscopic gastric wedge resection: a case report.

Hayashi M, Kawakubo H, Mayanagi S, Nakamura R, Suda K, Wada N, Kitagawa Y.

World J Surg Oncol. 2018 Aug 8;16(1):161. doi: 10.1186/s12957-018-1460-0.

20.

Postoperative Pneumonia is Associated with Long-Term Oncologic Outcomes of Definitive Chemoradiotherapy Followed by Salvage Esophagectomy for Esophageal Cancer.

Takeuchi M, Kawakubo H, Mayanagi S, Yoshida K, Fukuda K, Nakamura R, Suda K, Wada N, Takeuchi H, Kitagawa Y.

J Gastrointest Surg. 2018 Nov;22(11):1881-1889. doi: 10.1007/s11605-018-3857-z. Epub 2018 Jul 6.

PMID:
29980971
21.

Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.

Matsuda T, Takeuchi H, Sakurai T, Mayanagi S, Booka E, Fujita T, Higuchi H, Taguchi J, Hamamoto Y, Takaishi H, Kawakubo H, Okamoto M, Sunamura M, Kawakami Y, Kitagawa Y.

Oncol Lett. 2018 Jul;16(1):1348-1356. doi: 10.3892/ol.2018.8734. Epub 2018 May 17.

22.

Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept.

Takeuchi M, Takeuchi H, Kawakubo H, Shimada A, Nakahara T, Mayanagi S, Niihara M, Fukuda K, Nakamura R, Suda K, Wada N, Kitagawa Y.

Gastric Cancer. 2019 Jan;22(1):223-230. doi: 10.1007/s10120-018-0840-z. Epub 2018 May 24.

PMID:
29799060
23.

Technical feasibility and oncologic safety of diagnostic endoscopic resection for superficial esophageal cancer.

Takeuchi M, Suda K, Hamamoto Y, Kato M, Mayanagi S, Yoshida K, Fukuda K, Nakamura R, Wada N, Kawakubo H, Takeuchi H, Yahagi N, Kitagawa Y.

Gastrointest Endosc. 2018 Sep;88(3):456-465. doi: 10.1016/j.gie.2018.04.2361. Epub 2018 May 8.

PMID:
29750982
24.

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.

Mayanagi S, Kashiwabara K, Honda M, Oba K, Aoyama T, Kanda M, Maeda H, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T.

Dis Colon Rectum. 2018 Jul;61(7):803-808. doi: 10.1097/DCR.0000000000001002.

25.

Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials.

Kanda M, Oba K, Aoyama T, Kashiwabara K, Mayanagi S, Maeda H, Honda M, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T; Japanese Foundation for Multidisciplinary Treatment of Cancer.

Dis Colon Rectum. 2018 Apr;61(4):461-471. doi: 10.1097/DCR.0000000000001022.

PMID:
29521828
26.

Perioperative Risk Calculator Predicts Long-Term Oncologic Outcome for Patients with Esophageal Carcinoma.

Takeuchi M, Takeuchi H, Kawakubo H, Booka E, Mayanagi S, Fukuda K, Nakamura R, Suda K, Wada N, Kitagawa Y.

Ann Surg Oncol. 2018 Mar;25(3):837-843. doi: 10.1245/s10434-017-6311-7. Epub 2017 Dec 28.

PMID:
29282603
27.

Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials.

Honda M, Oba K, Akiyoshi T, Maeda H, Kashiwabara K, Kanda M, Mayanagi S, Aoyama T, Hamada C, Sadahiro S, Fukunaga Y, Ueno M, Sakamoto J, Saji S, Yoshikawa T.

Oncotarget. 2017 Oct 12;8(58):99150-99160. doi: 10.18632/oncotarget.21845. eCollection 2017 Nov 17.

28.

Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials.

Maeda H, Kashiwabara K, Aoyama T, Oba K, Honda M, Mayanagi S, Kanda M, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T.

J Cancer. 2017 Oct 23;8(19):4057-4064. doi: 10.7150/jca.21365. eCollection 2017.

29.

Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials.

Aoyama T, Kashiwabara K, Oba K, Honda M, Sadahiro S, Hamada C, Maeda H, Mayanagi S, Kanda M, Sakamoto J, Saji S, Yoshikawa T.

Cancer Med. 2017 Nov;6(11):2523-2530. doi: 10.1002/cam4.1208. Epub 2017 Sep 25.

30.

Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer.

Mayanagi S, Tsubosa Y, Omae K, Niihara M, Uchida T, Tsushima T, Yokota T, Sato H, Naito T, Yasui H.

Ann Surg Oncol. 2017 Nov;24(12):3741-3747. doi: 10.1245/s10434-017-6020-2. Epub 2017 Aug 31.

31.

Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials.

Aoyama T, Oba K, Honda M, Sadahiro S, Hamada C, Mayanagi S, Kanda M, Maeda H, Kashiwabara K, Sakamoto J, Saji S, Yoshikawa T.

Cancer Med. 2017 Jul;6(7):1573-1580. doi: 10.1002/cam4.1126. Epub 2017 Jun 22.

32.

Translation, validation of the EORTC esophageal cancer quality-of-life questionnaire for Japanese with esophageal squamous cell carcinoma: analysis in thoraco-laparoscopic esophagectomy versus open esophagectomy.

Fujita T, Okada N, Sato T, Mayanagi S, Kanamori J, Daiko H.

Jpn J Clin Oncol. 2016 Jul;46(7):615-21. doi: 10.1093/jjco/hyw040. Epub 2016 Apr 7.

PMID:
27056967
33.

Thermogenesis induced by amino acid administration prevents intraoperative hypothermia and reduces postoperative infectious complications after thoracoscopic esophagectomy.

Fujita T, Okada N, Kanamori J, Sato T, Mayanagi S, Torigoe K, Oshita A, Yamamoto H, Daiko H.

Dis Esophagus. 2017 Jan 1;30(1):1-7. doi: 10.1111/dote.12460.

PMID:
27003457
34.

Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.

Mayanagi S, Kitago M, Sakurai T, Matsuda T, Fujita T, Higuchi H, Taguchi J, Takeuchi H, Itano O, Aiura K, Hamamoto Y, Takaishi H, Okamoto M, Sunamura M, Kawakami Y, Kitagawa Y.

Cancer Sci. 2015 Apr;106(4):397-406. doi: 10.1111/cas.12621. Epub 2015 Mar 9.

35.
36.

Intra-abdominal desmoid tumor mimicking gastric cancer recurrence: a case report.

Okamura A, Takahashi T, Saikawa Y, Mayanagi S, Fukuda K, Nakamura R, Wada N, Kawakubo H, Omori T, Takeuchi H, Sasaki A, Kitagawa Y.

World J Surg Oncol. 2014 May 10;12:146. doi: 10.1186/1477-7819-12-146.

37.

Suitability of sentinel node mapping as an index of metastasis in early gastric cancer following endoscopic resection.

Mayanagi S, Takeuchi H, Kamiya S, Niihara M, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Nakahara T, Mukai M, Kitagawa Y.

Ann Surg Oncol. 2014 Sep;21(9):2987-93. doi: 10.1245/s10434-014-3662-1. Epub 2014 Mar 31.

PMID:
24682720
38.

Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia.

Mayanagi S, Niihara M, Goto H, Yokota T, Tabuse H, Yasui H, Ogawa H, Nishimura T, Kusafuka K, Tsubosa Y.

Esophagus. 2013;10:258-263. Epub 2013 Aug 28.

39.

The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer.

Mayanagi S, Onitsuka T, Nakagawa M, Sato H, Kitagawa Y, Tsubosa Y.

World J Surg. 2014 Jan;38(1):144-9. doi: 10.1007/s00268-013-2229-9.

Supplemental Content

Loading ...
Support Center